SG11201408340SA - Angiopoietin-like 4 antibody and a method of its use in cancer treatment - Google Patents
Angiopoietin-like 4 antibody and a method of its use in cancer treatmentInfo
- Publication number
- SG11201408340SA SG11201408340SA SG11201408340SA SG11201408340SA SG11201408340SA SG 11201408340S A SG11201408340S A SG 11201408340SA SG 11201408340S A SG11201408340S A SG 11201408340SA SG 11201408340S A SG11201408340S A SG 11201408340SA SG 11201408340S A SG11201408340S A SG 11201408340SA
- Authority
- SG
- Singapore
- Prior art keywords
- nanyang
- tct
- singapore
- cag
- ggg
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Abstract
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 20 February 2014 (20.02.2014) WIPOIPCT (10) International Publication Number WO 2014/027959 A1 (51) International Patent Classification: C07K16/18 (2006.01) A61P 35/04 (2006.01) A61K39/395 (2006.01) (21) International Application Number: (72) (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/SG2013/000331 6 August 2013 (06.08.2013) English English (30) Priority Data: 61/682,920 14 August 2012 (14.08.2012) US (71) Applicant: NANYANG TECHNOLOGICAL UNIVER SITY [SG/SG]; 50 Nanyang Avenue, Singapore 639798 (SG). Inventors: LESCAR, Julien; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). WONG, Yee Hwa; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). CHUA, Wei Min Edmond; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). TAN, Nguan Soon Andrew; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). CHONG, Han Chung Kelvin; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). TAN, Ming Jie; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). HUANG, Roy- ston-Luke; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). [Continued on next page] (54) Title: ANGIOPOIETIN-LIKE 4 ANTIBODY AND A METHOD OF ITS USE IN CANCER TREATMENT goc akc gag ctc ocfc cag tct c 1 2 3 4 S 5 7 0 I E L T Q S l get tct ttg get gtg tct eta ggg <og agg gee occ 9 1® 11 12 13 14 15 l« 17 IS 19 2& ASLAVSLCQRAT (57) Abstract: An antibody that binds C terminal region of angiopoietin like protein its use and methods 4 of treating can cer with the same. otc ice tgc esg get age caa ogt gtt gat tot gat ggt got ogt tat ttg aac tgg tfcc 21 22 23 24 25 26 17 2S 2fl 3® 31 32 33 iM SS 56 3? tt 39 4& ISCXASQSVDfDCOSYLtlHF • Li - caa cag aaa c eg gga cag cca ccc ao a ctc ctc ctc tat oct gca tcc act eta gca tct 41 42 43 44 -15 46 4 7 43 49 SB 31 52 S3 54 55 56 S? 58 59 68 4QKPGQPPKILIYTASNLES < 12 §ga ate cca gcc agg tfct ogt ggc: agt ggg tct ggg oca gar, ttc occ etc aac otc est 62 63 (A S5 66 6? 68 69 TO ?1 12 73 74 75 76 77 78 79 fi» CSPARPSGSC. SCTOFTLMIK cCt gtg g<% &Q gag gat get gca acc tat tac tgt oag cos agt oat gag got ccg tg$ SI 82 S3 W SS 84 4? S3 89 S& 91 93 W 95 9® £7 98 99 1M PYEEEOfiATVyCQQSNEDPW 13 ocg tic ggt §ga ggc ate oag ttg gca atfl <aaa egg Ifll 182 103 184 185 106 US? 163 1B9 110 111 112 TF6GGTKLE2KS Heavy chain cag gfcg caa ctg cog gag tct gac cct ggg eta ttg aag ccc tea cag acc ctc agt ctg i 2 3 4 5 6 7 3 9 1» U 12 13 14 15 16 17 18 13 itt QV QlQfSGP&ZlKPSQTLSL <jct tgt tct ttc tct ggg ttt tco ctg age set tct ggt atg ggt gto ggc tgg ott tgt 21 22 23 24 25 26 27 2S 29 3& 31 32 33 34 35 .36 37 38 39 4ft TCSFSCFSLSTSGMGVGHIR Hi > cog cct tea ggg aag ggt ctg gag tgg ctg gca cac att tgg tgg gat got got cog tac 41 42 43 44 45 +6 47 48 49 5& 51 52 S3 S4 55 56 57 58 59 £0 QPS&KCLE ffLAH ItfHODDKy < H2 tat aac cca tcc ctg aag age cag ctc aco ate tee asg 61 62 63 64 6S £6 67 S2 63 ?& 72 72 73 VNPSLKSQiTISS $at acc tcc aga aac cag gto 74 75 76 77 74 ?3 I® £> T S ft H $ V ir. o\ i> rs o ttc ctc aag ate ate ogt gtg gac act gca gat act gcc act toe tac tgt get cga add B1 82 83 34 85 S6 &7 &Z S9 3d il «2 93 54 95 S6 37 9S 93 ICS FLKttSVftTAOTATYVCik'ftK gac tac gge agt ogt tac ©ac toe tgg ggc cca ggg occ acg gtc acc gtc tcc Ifll 102 m M 105 106 107 IdS 169 110 111 112 113 114 115 116 117 118 0*6 SSYfiyWGfiCTTVTyS H3 > O CJ o & WO 2014/027959 A11II llll IIII III III Hill III III III Hill 111 II lllll llll 111 mill llll 111 llll (74) Agent: VIERING, JENTSCHURA & PARTNER LLP; P.O. Box 1088, Rochor Post Office, Rochor Road, Singa pore 911833 (SG). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) — with sequence listing part of description (Rule 5.2(a))
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261682920P | 2012-08-14 | 2012-08-14 | |
PCT/SG2013/000331 WO2014027959A1 (en) | 2012-08-14 | 2013-08-06 | Angiopoietin-like 4 antibody and a method of its use in cancer treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201408340SA true SG11201408340SA (en) | 2015-01-29 |
Family
ID=50101350
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201408340SA SG11201408340SA (en) | 2012-08-14 | 2013-08-06 | Angiopoietin-like 4 antibody and a method of its use in cancer treatment |
SG10201701165TA SG10201701165TA (en) | 2012-08-14 | 2013-08-06 | Angiopoietin-like 4 antibody and a method of its use in cancer treatment |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201701165TA SG10201701165TA (en) | 2012-08-14 | 2013-08-06 | Angiopoietin-like 4 antibody and a method of its use in cancer treatment |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150210758A1 (en) |
EP (1) | EP2885319B1 (en) |
CN (1) | CN104768972B (en) |
SG (2) | SG11201408340SA (en) |
WO (1) | WO2014027959A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201301313D0 (en) | 2013-01-25 | 2013-03-06 | Univ Singapore | Respiratory Tract Infections |
WO2016020882A2 (en) | 2014-08-07 | 2016-02-11 | Novartis Ag | Angiopoetin-like 4 (angptl4) antibodies and methods of use |
CU24453B1 (en) | 2014-08-07 | 2019-11-04 | Novartis Ag | ANTI-PROTEIN ANTIBODIES SIMILAR TO ANGIOPOYETIN 4 |
WO2021221565A1 (en) * | 2020-04-27 | 2021-11-04 | Nanyang Technological University | HUMANIZED MONOCLONAL ANTIBODY AGAINST cANGPTL4 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
WO1981001145A1 (en) | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
GB8705477D0 (en) | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
US4975278A (en) | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
US6214388B1 (en) | 1994-11-09 | 2001-04-10 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
US7117096B2 (en) | 2001-04-17 | 2006-10-03 | Abmaxis, Inc. | Structure-based selection and affinity maturation of antibody library |
KR20030033007A (en) | 2001-05-31 | 2003-04-26 | 코울터 파머수티컬, 인코포레이티드 | Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
CN101044164A (en) * | 2004-07-20 | 2007-09-26 | 健泰科生物技术公司 | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
EP2488640B1 (en) * | 2009-10-14 | 2018-09-26 | Nanyang Technological University | Antiproliferative agent |
EP2742361A4 (en) * | 2011-08-08 | 2015-03-04 | Univ Nanyang Tech | Angiopoietin-like 4 and its use in modulating cell leakiness |
-
2013
- 2013-08-06 SG SG11201408340SA patent/SG11201408340SA/en unknown
- 2013-08-06 CN CN201380040111.9A patent/CN104768972B/en active Active
- 2013-08-06 SG SG10201701165TA patent/SG10201701165TA/en unknown
- 2013-08-06 US US14/421,772 patent/US20150210758A1/en not_active Abandoned
- 2013-08-06 WO PCT/SG2013/000331 patent/WO2014027959A1/en active Application Filing
- 2013-08-06 EP EP13829237.0A patent/EP2885319B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
SG10201701165TA (en) | 2017-03-30 |
WO2014027959A1 (en) | 2014-02-20 |
CN104768972B (en) | 2019-12-06 |
EP2885319B1 (en) | 2019-10-09 |
EP2885319A1 (en) | 2015-06-24 |
EP2885319A4 (en) | 2016-06-01 |
US20150210758A1 (en) | 2015-07-30 |
CN104768972A (en) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201805268XA (en) | T cell receptors specific for the ny-eso-1 tumor antigen-hla-a*02 complex | |
SG11201403106SA (en) | Anti-phf-tau antibodies and their uses | |
SG11201804398XA (en) | Method for producing rna molecule compositions | |
SG11201803933PA (en) | Optical metrology of lithographic processes using asymmetric sub-resolution features to enhance measurement | |
SG11201407710VA (en) | Compositions comprising short-acting benzodiazepines | |
SG11201408605UA (en) | Methods for biodegradable derivatization of cellulosic surfaces | |
SG11201811003PA (en) | Anti-pd-l1 antibodies and uses thereof | |
SG11201408269PA (en) | Nanosilica coating assembly with enhanced durability | |
SG11201910027YA (en) | Bispecific antibody against ox40 and ctla-4 | |
SG11201407028WA (en) | St2l antagonists and methods of use | |
SG11201408769QA (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
SG11201408536WA (en) | METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF | |
SG11201408362SA (en) | Production of long chain polyunsaturated fatty acids in plant cells | |
SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
SG11201408312UA (en) | Method of preparing a composition based on hyaluronic acid | |
SG11201408340SA (en) | Angiopoietin-like 4 antibody and a method of its use in cancer treatment | |
SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
SG11201901468SA (en) | Antibodies with reduced binding to process impurities | |
SG11201408037SA (en) | Humanized anti-trka antibodies with amino acid substitutions | |
SG11201806485RA (en) | Pyrrolobenzodiazepine conjugates | |
SG11201407817RA (en) | Coating a substrate web by atomic layer deposition | |
SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
SG11201407650VA (en) | Composition and process for stripping photoresist from a surface including titanium nitride | |
SG11201408103XA (en) | Polyurethane-based waterproofing composition for the water-proofing of concrete structures | |
SG11201806791VA (en) | Lubricant for a two-stroke marine engine |